Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 3, 2026

Evolution of Advanced Combination Treatment in Inflammatory Bowel Disease.

Ask AI
Bookmark
Share

Authors

AJArpita JajooKMKatherine MargolinBLBerkeley N. Limketkai

Discussion

Loading...

Member takes

Overview

Observational analysis reports 69% response rates in inflammatory bowel disease with advanced combination treatment, highlighting its potential benefits.

Key Points

  • Clinical remission rates of advanced combination treatment reach 59%, showing promise for treating inflammatory bowel disease.
  • Initial trials indicate that patients may achieve endoscopic remission or respond positively to advanced combination treatment.
  • Combination therapy addresses multiple inflammatory pathways, targeting long-standing refractory disease effectively.
  • Increased adverse events may arise from combining advanced combination treatment with immunomodulators or corticosteroids.

Cite This Study

Jajoo et al. (2025) studied this question.

synapsesocial.com/papers/69a7684abadf0bb9e87e4419
Ask AI
Bookmark
Share